Oral Antineoplastic Agents: Assessing the Delay in Care.

作者: Brandi Anders , Alexandra Shillingburg , Michael Newton

DOI: 10.1155/2015/512016

关键词:

摘要: The study was undertaken to determine the length of time between when a prescription for an oral antineoplastic agent is written by provider and medication received patient identify risk factors that significantly increase receipt. First-time fill prescriptions agents were identified. date determined. A retrospective review completed gather additional information, including prescribed medication, indication, insurance coverage, assistance program use, dispensing pharmacy, prior authorization requirements. data analyzed through multivariate statistical analysis used may total 58 patients included in study. median 8 days elapsed it patient. Medication prescribed, absence Risk Evaluation Mitigation Strategies (REMS) program, type are increased An understanding involved, as well affecting delivery prescriptions, will help healthcare providers better plan prepare use agents.

参考文章(6)
Saul N. Weingart, Elizabeth Brown, Peter B. Bach, Kirby Eng, Shirley A. Johnson, Timothy M. Kuzel, Terry S. Langbaum, R. Donald Leedy, Raymond J. Muller, Lee N. Newcomer, Susan O’Brien, Denise Reinke, Mark Rubino, Leonard Saltz, Ronald S. Walters, NCCN Task Force Report: Oral chemotherapy. Journal of The National Comprehensive Cancer Network. ,vol. 6, ,(2008) , 10.6004/JNCCN.2008.2003
Giuseppe Luigi Banna, Elena Collovà, Vittorio Gebbia, Helga Lipari, Pietro Giuffrida, Sebastiano Cavallaro, Rosaria Condorelli, Calogero Buscarino, Paolo Tralongo, Francesco Ferraù, Anticancer oral therapy: Emerging related issues Cancer Treatment Reviews. ,vol. 36, pp. 595- 605 ,(2010) , 10.1016/J.CTRV.2010.04.005
Jennifer Bowman, Amy Rousseau, David Silk, Catherine Harrison, Access To Cancer Drugs In Medicare Part D: Formulary Placement And Beneficiary Cost Sharing In 2006 Health Affairs. ,vol. 25, pp. 1240- 1248 ,(2006) , 10.1377/HLTHAFF.25.5.1240
Sonya Blesser Streeter, Lee Schwartzberg, Nadia Husain, Michael Johnsrud, Patient and Plan Characteristics Affecting Abandonment of Oral Oncolytic Prescriptions Journal of Oncology Practice. ,vol. 7, pp. 46s- 51s ,(2011) , 10.1200/JOP.2011.000316
Debbie A. McCue, Lisa K. Lohr, Amy M. Pick, Improving Adherence to Oral Cancer Therapy in Clinical Practice Pharmacotherapy. ,vol. 34, pp. 481- 494 ,(2014) , 10.1002/PHAR.1399
Benedicte Gourieux, Dominique Leveque, Amina Delpeuch, New Anticancer Agents: Role of Clinical Pharmacy Services Anticancer Research. ,vol. 34, pp. 1573- 1578 ,(2014)